Compare Symbotic Inc (SYM) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Symbotic Inc vs UnitedHealth Group Inc — how do they compare? Symbotic Inc trades at $41.86 (market cap $5.21B), while UnitedHealth Group Inc trades at $402.67 (market cap $371.19B). The key difference: UnitedHealth Group Inc is far larger — about 71.2× Symbotic Inc's market cap, and UnitedHealth Group Inc pays a 2.27% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals.
| SYM | UNH | |
|---|---|---|
Market Cap | $5.21B | $371.19B |
Sector | Technology | Health |
52-Week High | $87.30 | $436.35 |
52-Week Low | $38.57 | $259.02 |
Enterprise Value | $3.46B | $417.88B |
Dividend Yield | — | 2.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SYM trades at $40.18, down 1.46% with bearish technical signals despite analyst optimism. Recent Q3 2026 earnings missed estimates at $0.09 vs. $0.13 expected, though revenue grew 21.7% year-over-year. The company shows weak profitability with a 0.31% net margin but maintains strong cash flow generation of $517 million in 2025. Technical indicators show bearish momentum with support at $39 and resistance at $42.
Outlook remains mixed with 61% analyst buy ratings and $60 consensus target suggesting 49% upside, but execution risks persist after recent earnings misses. Key catalysts include margin expansion and system deployments, while risks include competitive pressure and volatile earnings performance. The stock offers growth potential but requires careful monitoring of quarterly execution.
UnitedHealth Group (UNH) trades at $402.19, down 1.2% in the last session, with a bearish technical signal but strong analyst support. The company reported revenue of $447.57B in 2025, with net income of $12.06B, and has consistently beaten EPS estimates in recent quarters. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
Outlook remains positive due to aging demographics and Medicare growth, though regulatory risks and margin pressure present challenges. With 82.7% of analysts rating it a Buy and a consensus price target of $476.50, the stock offers upside potential, balanced by litigation and competitive threats in the managed care sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
